Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH 2017 | GATA2 and its influence on AML

Emery Bresnick • 12 Oct 2017
ESH 2017
Acute Myeloid Leukemia Leukemia

As the roles of various proteins within the human body become clearer, novel research can develop to produce effective therapies with a high specificity. In this video, Emery Bresnick, PhD, from the University of Wisconsin, Wisconsin, WI, speaking from the International Conference on Acute Myeloid Leukaemia 2017 in Estoril, Portugal by the European School of Haematology (ESH), discusses the link between GATA2 and acute myeloid leukemia. Dr Bresnick touches upon the mechanism of action of the gene, the influence it has upon progenitor and stem cells, and the effects of coding and non-coding mutations of GATA2.

More from Emery Bresnick

2:13
Collaboration and cooperation in hematology-oncology research
Emery Bresnick • 12 Oct 2017

Related Videos

1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals